HRP20240254T1 - Racionalno razvijen oslabljen soj afričke svinjske gripe štiti od problema s izolatom roditeljskog virusa georgia iz 2007. - Google Patents
Racionalno razvijen oslabljen soj afričke svinjske gripe štiti od problema s izolatom roditeljskog virusa georgia iz 2007. Download PDFInfo
- Publication number
- HRP20240254T1 HRP20240254T1 HRP20240254TT HRP20240254T HRP20240254T1 HR P20240254 T1 HRP20240254 T1 HR P20240254T1 HR P20240254T T HRP20240254T T HR P20240254TT HR P20240254 T HRP20240254 T HR P20240254T HR P20240254 T1 HRP20240254 T1 HR P20240254T1
- Authority
- HR
- Croatia
- Prior art keywords
- asfv
- δ9gl
- δuk
- virus
- vaccine
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims 9
- 208000007407 African swine fever Diseases 0.000 title 1
- 230000002238 attenuated effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 241000282887 Suidae Species 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 2
- 241000701386 African swine fever virus Species 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12061—Methods of inactivation or attenuation
- C12N2710/12062—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12071—Demonstrated in vivo effect
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
Claims (8)
1. Rekombinantni mutirani virus afričke svinjske kuge – izolat Georgia 2007 (ASFV-G) virusa Δ9GL/ΔUK.
2. Rekombinantni mutirani virus ASFV-G Δ9GL/ΔUK ima SEQ ID BR.: 3.
3. Sastav cjepiva sadrži rekombinantni mutirani virus ASFV-G Δ9GL/ΔUK u skladu s patentnim zahtjevom 1 ili patentnim zahtjevom 2.
4. Živo razblaženo cjepivo ASFV-G Δ9GL/ΔUK koristi se kao zaštita svinja od ASFV-G, pri čemu cjepivo sadrži rekombinantni mutirani virus ASFV-G Δ9GL/ΔUK u skladu s patentnim zahtjevom 1 ili patentnim zahtjevom 2 u količini učinkovitoj za zaštitu navedenih svinja od kliničke ASF-G.
5. Cjepivo koje se koristi u skladu s patentnim zahtjevom 4, pri čemu količina učinkovita za zaštitu navedenih svinja od kliničke ASF-G iznosi od 104 HAD50 do 106 HAD50 virusa ASFV-G Δ9GL/ΔUK.
6. Metoda diferencijacije između sisavca cijepljenog živim razblaženim cjepivom ASFV-G Δ9GL/ΔUK, koje sadrži rekombinantni mutirani virus ASFV-G Δ9GL/ΔUK u skladu s patentnim zahtjevom 1 ili patentnim zahtjevom 2 od necijepljenog sisavca zaraženog ASFV-G, sastoji se od: analize uzorka uzetog od ispitivanog sisavca u kojem treba procijeniti prisustvo gena uobičajeno prisutnog u divljem tipu ASFV-G, ali ne i u virusu ASFV-G Δ9GL/ΔUK, koji se koristi za cijepljenje navedenog sisavca kojeg ispitujemo.
7. Metoda iz patentnog zahtjeva 6, pri čemu se korak analize navedenog uzorka provodi pomoću ispitivanja PCR.
8. Metoda iz patentnog zahtjeva 6, pri čemu se korak analize provodi pomoću ispitivanja uočavanjem antitijela ili ELISOM.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/200,407 US9808520B1 (en) | 2016-07-01 | 2016-07-01 | Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate |
| EP17821008.4A EP3478705B1 (en) | 2016-07-01 | 2017-06-26 | A rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate |
| PCT/US2017/039277 WO2018005358A1 (en) | 2016-07-01 | 2017-06-26 | A rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20240254T1 true HRP20240254T1 (hr) | 2024-05-10 |
Family
ID=60189680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20240254TT HRP20240254T1 (hr) | 2016-07-01 | 2017-06-26 | Racionalno razvijen oslabljen soj afričke svinjske gripe štiti od problema s izolatom roditeljskog virusa georgia iz 2007. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9808520B1 (hr) |
| EP (1) | EP3478705B1 (hr) |
| JP (1) | JP7121950B2 (hr) |
| KR (1) | KR102443074B1 (hr) |
| CN (1) | CN109952310B (hr) |
| AU (1) | AU2017288932B2 (hr) |
| BR (1) | BR112018076633A2 (hr) |
| CA (1) | CA3029552A1 (hr) |
| CL (1) | CL2018003769A1 (hr) |
| DK (1) | DK3478705T5 (hr) |
| EA (1) | EA201990085A1 (hr) |
| ES (1) | ES2971606T3 (hr) |
| FI (1) | FI3478705T3 (hr) |
| GE (1) | GEP20207186B (hr) |
| HR (1) | HRP20240254T1 (hr) |
| HU (1) | HUE065240T2 (hr) |
| LT (1) | LT3478705T (hr) |
| MX (1) | MX2019000048A (hr) |
| MY (1) | MY197376A (hr) |
| PH (1) | PH12018502684A1 (hr) |
| PL (1) | PL3478705T3 (hr) |
| PT (1) | PT3478705T (hr) |
| RS (1) | RS65124B1 (hr) |
| SG (1) | SG11201811370XA (hr) |
| SI (1) | SI3478705T1 (hr) |
| UA (1) | UA125584C2 (hr) |
| WO (1) | WO2018005358A1 (hr) |
| ZA (1) | ZA201900259B (hr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017128039A1 (zh) * | 2016-01-26 | 2017-08-03 | 浙江大学 | 基因组合及其用途 |
| EP3787679A4 (en) * | 2019-07-11 | 2022-03-30 | Aptimmune Biologics, Inc. | METHODS OF CULTIVATING AFRICAN SWINE FEVER VIRUS IN PORCINE LUNG ALVEOLAR MACROPHAGE CELLS |
| CN110302371B (zh) * | 2019-08-21 | 2023-05-26 | 军事科学院军事医学研究院军事兽医研究所 | 灭活asfv作为复合疫苗的免疫攻毒保护成分的用途 |
| US11007263B2 (en) | 2019-09-24 | 2021-05-18 | The United States Of America, As Represented By The Secretary Of Agriculture | Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L |
| JP7382628B2 (ja) * | 2019-10-11 | 2023-11-17 | 国立研究開発法人農業・食品産業技術総合研究機構 | アフリカ豚コレラウイルスの製造方法及び検出方法 |
| CN110760617B (zh) * | 2019-11-26 | 2021-12-21 | 华中农业大学 | 检测非洲猪瘟病毒野毒的实时荧光pcr引物探针组合及试剂盒 |
| KR20210087810A (ko) | 2020-01-03 | 2021-07-13 | 주식회사 중앙백신연구소 | 신규한 아프리카돼지열병의 예방 및 치료를 위한 바이러스 백신조성물 |
| CN111925994B (zh) * | 2020-07-03 | 2023-05-26 | 中国农业科学院兰州兽医研究所 | 一种dp71l基因缺失的重组非洲猪瘟病毒及其制备方法和应用 |
| CN112063592A (zh) * | 2020-07-10 | 2020-12-11 | 中国农业科学院兰州兽医研究所 | 非洲猪瘟多基因联合缺失减毒株的构建及作为疫苗的应用 |
| CN111748563A (zh) * | 2020-07-10 | 2020-10-09 | 中国农业科学院兰州兽医研究所 | 非洲猪瘟基因缺失弱毒株的构建及其作为疫苗的应用 |
| CN111996175B (zh) * | 2020-09-04 | 2023-11-21 | 军事科学院军事医学研究院军事兽医研究所 | 缺失e66l、i267l基因的非洲猪瘟减毒及活疫苗 |
| WO2022107793A1 (ja) * | 2020-11-20 | 2022-05-27 | 国立研究開発法人農業・食品産業技術総合研究機構 | 不死化豚胎子小腸マクロファージ |
| CA3202683A1 (en) | 2020-12-24 | 2022-06-30 | Erwin VAN DEN BORN | African swine fever diva immunoassay |
| CN112852761B (zh) * | 2021-03-08 | 2022-08-23 | 中国农业科学院兰州兽医研究所 | 基因缺失减毒非洲猪瘟病毒株的构建及作为疫苗的应用 |
| CN114392345B (zh) * | 2021-03-11 | 2023-08-25 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | E199l蛋白在促进细胞凋亡中的用途及方法 |
| CN113061588B (zh) * | 2021-05-20 | 2023-08-01 | 军事科学院军事医学研究院军事兽医研究所 | 缺失i226r基因的非洲猪瘟病毒减毒株及其活疫苗 |
| US11801296B2 (en) * | 2021-06-30 | 2023-10-31 | The United States Of America, As Represented By The Secretary Of Agriculture | Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R |
| CN114107228B (zh) * | 2021-11-11 | 2023-06-13 | 中国农业科学院兰州兽医研究所 | 缺失十二个基因的减毒非洲猪瘟病毒株的构建及其作为疫苗的应用 |
| CN113831394B (zh) * | 2021-11-29 | 2022-04-12 | 中国人民解放军军事科学院军事医学研究院 | 一种非洲猪瘟病毒asfv基因的重组病毒组合及由其制备的疫苗 |
| WO2024137601A2 (en) * | 2022-12-21 | 2024-06-27 | Colorado State University Research Foundation | Systems, methods, and compositions for preparing vaccines comprising inactivated/attenuated pathogens |
| WO2024189198A1 (en) | 2023-03-16 | 2024-09-19 | Intervet International B.V. | A vaccine for protecting a pregnant swine against african swine fever |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8610106D0 (en) * | 1986-04-25 | 1986-05-29 | Central Blood Lab Authority | Human igm-producing heterohybridoma |
| US8846055B2 (en) * | 2006-05-30 | 2014-09-30 | The United States Of America, As Represented By The Secretary Of Agriculture | Virulence determinant within the E2 structural glycoprotein of classical swine fever virus |
| US9352032B2 (en) * | 2014-03-07 | 2016-05-31 | The United States Of America As Represented By The Secretary Of Agriculture | Live attenuated antigenically marked classical swine fever vaccine |
| GB201410971D0 (en) * | 2014-06-19 | 2014-08-06 | Pirbright Inst The | Vaccine |
| US9463234B2 (en) * | 2014-09-24 | 2016-10-11 | The United States Of America, As Represented By The Secretary Of Agriculture | Attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate |
| US9528094B2 (en) * | 2014-11-10 | 2016-12-27 | The United States Of America, As Represented By The Secretary Of Agriculture | Attenuated African swine fever virus vaccine based in the deletion of MGF genes |
-
2016
- 2016-07-01 US US15/200,407 patent/US9808520B1/en active Active
-
2017
- 2017-06-26 CN CN201780053651.9A patent/CN109952310B/zh active Active
- 2017-06-26 HU HUE17821008A patent/HUE065240T2/hu unknown
- 2017-06-26 HR HRP20240254TT patent/HRP20240254T1/hr unknown
- 2017-06-26 AU AU2017288932A patent/AU2017288932B2/en active Active
- 2017-06-26 WO PCT/US2017/039277 patent/WO2018005358A1/en unknown
- 2017-06-26 BR BR112018076633-0A patent/BR112018076633A2/pt unknown
- 2017-06-26 SI SI201731488T patent/SI3478705T1/sl unknown
- 2017-06-26 KR KR1020197003279A patent/KR102443074B1/ko active IP Right Grant
- 2017-06-26 LT LTEPPCT/US2017/039277T patent/LT3478705T/lt unknown
- 2017-06-26 MY MYPI2018002721A patent/MY197376A/en unknown
- 2017-06-26 UA UAA201900970A patent/UA125584C2/uk unknown
- 2017-06-26 DK DK17821008.4T patent/DK3478705T5/da active
- 2017-06-26 PL PL17821008.4T patent/PL3478705T3/pl unknown
- 2017-06-26 MX MX2019000048A patent/MX2019000048A/es unknown
- 2017-06-26 RS RS20240124A patent/RS65124B1/sr unknown
- 2017-06-26 ES ES17821008T patent/ES2971606T3/es active Active
- 2017-06-26 CA CA3029552A patent/CA3029552A1/en active Pending
- 2017-06-26 GE GEAP201714984A patent/GEP20207186B/en unknown
- 2017-06-26 JP JP2018568233A patent/JP7121950B2/ja active Active
- 2017-06-26 FI FIEP17821008.4T patent/FI3478705T3/fi active
- 2017-06-26 SG SG11201811370XA patent/SG11201811370XA/en unknown
- 2017-06-26 EA EA201990085A patent/EA201990085A1/ru unknown
- 2017-06-26 PT PT178210084T patent/PT3478705T/pt unknown
- 2017-06-26 EP EP17821008.4A patent/EP3478705B1/en active Active
-
2018
- 2018-12-19 PH PH12018502684A patent/PH12018502684A1/en unknown
- 2018-12-21 CL CL2018003769A patent/CL2018003769A1/es unknown
-
2019
- 2019-01-15 ZA ZA2019/00259A patent/ZA201900259B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20240254T1 (hr) | Racionalno razvijen oslabljen soj afričke svinjske gripe štiti od problema s izolatom roditeljskog virusa georgia iz 2007. | |
| Singh et al. | Development of a monoclonal antibody based competitive-ELISA for detection and titration of antibodies to peste des petits ruminants (PPR) virus | |
| Bowden et al. | Detection of antibodies specific for sheeppox and goatpox viruses using recombinant capripoxvirus antigens in an indirect enzyme-linked immunosorbent assay | |
| Rojas et al. | Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep | |
| Li et al. | Development of a blocking ELISA for detection of serum neutralizing antibodies against newly emerged duck Tembusu virus | |
| Bhoora et al. | Sequence heterogeneity in the gene encoding the rhoptry-associated protein-1 (RAP-1) of Babesia caballi isolates from South Africa | |
| Servat et al. | Evaluation of a Rapid Immunochromatographic Diagnostic Test for the detection of rabies from brain material of European mammals | |
| Aebischer et al. | Two newly developed Erns-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies | |
| Ma et al. | A nanoparticle-assisted PCR assay to improve the sensitivity for rapid detection and differentiation of wild-type pseudorabies virus and gene-deleted vaccine strains | |
| Knight‐Jones et al. | Global foot‐and‐mouth disease research update and gap analysis: 4‐diagnostics | |
| Marín-López et al. | CD8 T cell responses to an immunodominant epitope within the nonstructural protein NS1 provide wide immunoprotection against bluetongue virus in IFNAR−/− mice | |
| Batra et al. | Development and evaluation of loop-mediated isothermal amplification assay for rapid detection of Capripoxvirus | |
| Karki et al. | Canine morbillivirus (CDV): a review on current status, emergence and the diagnostics | |
| Otto et al. | Serological investigation of wild boars (Sus scrofa) and red foxes (Vulpes vulpes) as indicator animals for circulation of Francisella tularensis in Germany | |
| Güler et al. | Phylogenetic analysis of peste des petits ruminants virus from outbreaks in Turkey during 2008-2012 | |
| Mahmoud et al. | Prevalence of PPR-virus antibodies in sheep, goats and camels in Hail, Saudi Arabia | |
| Ellis et al. | Validation of an ELISA for the concurrent detection of total antibodies (IgM and IgG) to Rift Valley fever virus | |
| Aoki et al. | Surveillance for antibodies against six canine viruses in wild raccoons (Procyon lotor) in Japan | |
| von Rosen et al. | DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif | |
| KR101236203B1 (ko) | 구제역바이러스 ｓａｔ 2형 유전자재조합 단백질 항원, 단클론항체 및 이를 이용한 진단방법 | |
| Rajasekhar et al. | Recombinant hexon antigen based single serum dilution ELISA for rapid serological profiling against fowl adenovirus-4 causing hydropericardium syndrome in chickens | |
| Hu et al. | Development of a single-tube duplex EvaGreen real-time PCR for the detection and identification of EHV-1 and EHV-4 | |
| Mosallanejad et al. | A comparison between PCR and Immunochromatography assay (ICA) in diagnosis of hemorrhagic gastroenteritis caused by Canine parvovirus | |
| Gelaye et al. | Sheep and goat pox | |
| Shooshtari et al. | Capripoxvirus identification by PCR based on P32 gene |